As of Feb 12
| -0.0001 / -0.05%|
The 1 analysts offering 12-month price forecasts for Aeolus Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +525.31% increase from the last price of 0.20.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.